EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation

Victoria Aguilera, Sarai Romero Moreno, Isabel Conde, Angel Rubín, Angela Carvalho-Gomes, Mario Romero, Javier Zamora-Olaya, Miguel Angel Gómez-Bravo, Esteban Fuentes-Valenzuela, Cristina Dopazo, Nikita Bilbao, Antonio González und 11 weitere

Transplant International · 2025

DOI: 10.3389/ti.2025.14553 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant International, 2025. Verfasst von Victoria Aguilera und 22 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology and Liver Transplant Unit, La Fe Universitary and Politécnic Hospital, Instituto de Investigación Sanitaria (IIS) La Fe, Centro de Investi…. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Asociación Española para el Estudio del Hígado, Generalitat Valenciana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with hepatocellular carcinoma (HCC), undergoing liver transplantation (LT), cytomegalovirus reactivation (CMVr) may modulate the immune system to prevent tumor recurrence. In this multicenter retrospective study (2010–2015) involving 15 institutions, we assessed the effect of early CMVr in tumor recurrence rates among 771-LT HCC patients with tacrolimus-based immunosuppression (88% men, mean age 58 years). CMV prophylaxis was implemented for 19.7% of patients, while the rest were managed with preemptive therapy. The Milan criteria were met by 88% of patients. Microvascular invasion was present in 12.7% of explanted livers. The serum AFP level before transplantation was 5.1 (3–15) ng/mL. After a median follow-up of 7.4 years, 101 patients (13%) experienced HCC recurrence. CMVr occurred in 235 patients (30.5%) at a median of 41.5 days post-LT and 42 patients (5.6%) had CMV disease. Cumulative exposure to tacrolimus within the first 3 months after LT was similar among patients with and without CMVr. In a multivariate Cox regression analysis, factors associated with an increased rate of HCC recurrence included microvascular invasion [HR:2.82, CI95%:1.55–5.14; p 0.0001], donation after circulatory determination of death [HR:4.43,CI95%:1.52–12.9; p 0.006) and diameter of the main nodule at explant [HR:1.04, CI95%:1.02–1.06; p < 0.001]. Meanwhile CMVr [HR:0.46, CI95%:0.23–0.93, p 0.031] and MELD [HR:0.93, CI95%:0.87–0.99; p0.017] exhibited protective effects. In conclusion, early CMVr may protect against HCC recurrence. The underlying immune mechanisms warrant further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCarcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalCytomegalovirusVirus ActivationCytomegalovirus InfectionsHumansMaleMiddle AgedFemaleRetrospective StudiesAgedTacrolimusAdultImmunosuppressive Agents

Stichwörter der Autor:innen

Immunosupressioncytomegalovirusdonation after circulatory determination of deathhepatocellular carcinomaliver transplantationsurvival

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Hepatology and Liver Transplant Unit, La Fe Universitary and Politécnic Hospital, Instituto de Investigación Sanitaria (IIS) La Fe, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERE…
  • Hepatology and Liver Transplant Unit, La Fe Universitary and Politécnic Hospital, Valencia, Spain.
  • Hepatology and Liver Transplant Unit Trasplante Hepático, La Fe Universitary and Politécnic Hospital, Instituto de Investigación Sanitaria (IIS) La Fe, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas…
  • Laboratorio de Hepatología, Cirugía HBP y Trasplantes, Instituto de Investigación Sanitaria (IIS) La Fe, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Valencia, Spain.
  • Department of Hepatology and Liver Transplantation, HUGregorio Marañón, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
  • Department of Hepatology and Liver Transplantation, Hospital Universitario Reina Sofía, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC) and University of Córdoba, Córdoba, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Asociación Española para el Estudio del Hígado
  • Generalitat Valenciana

Zitieren

APA

Aguilera, V., Romero Moreno, S., Conde, I., Rubín, A., Carvalho-Gomes, A., Romero, M., Zamora-Olaya, J., Gómez-Bravo, M. A., Fuentes-Valenzuela, E., Dopazo, C., Bilbao, N., González, A., Sánchez-Martínez, A., Pascual, S., Rivera-Esteban, J., Herrero, J. I., Lorente, S., Cuadrado-Lavín, A., Nogueras, F., …, & Rodriguez-Perálvarez, M. (2025). Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplant International. https://doi.org/10.3389/ti.2025.14553

Vancouver

Aguilera V, Romero Moreno S, Conde I, Rubín A, Carvalho-Gomes A, Romero M, et al. Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplant International. 2025. doi:10.3389/ti.2025.14553

BibTeX
@article{Aguilera2025,
  author = {Aguilera, Victoria and Romero Moreno, Sarai and Conde, Isabel and Rubín, Angel and Carvalho-Gomes, Angela and Romero, Mario and Zamora-Olaya, Javier and Gómez-Bravo, Miguel Angel and Fuentes-Valenzuela, Esteban and Dopazo, Cristina and Bilbao, Nikita and González, Antonio and Sánchez-Martínez, Ana and Pascual, Sonia and Rivera-Esteban, Jesús and Herrero, José Ignacio and Lorente, Sara and Cuadrado-Lavín, Antonio and Nogueras, Flor and Martínez-Arenas, Laura and González-Grande, Rocío and Berenguer, Marina and Rodriguez-Perálvarez, Manuel},
  title = {Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.14553}
}
Kostenlos starten →